Arkansas 2025 Regular Session

Arkansas House Bill HB1079

Introduced
1/8/25  
Refer
1/13/25  
Report Pass
3/13/25  
Engrossed
3/18/25  
Refer
3/18/25  
Report Pass
4/1/25  
Refer
4/9/25  
Report Pass
4/10/25  
Enrolled
4/14/25  

Caption

To Mandate Coverage For Genetic Testing For An Inherited Gene Mutation For Certain Individuals; And To Mandate Coverage For Evidence-based Cancer Imaging For Certain Individuals.

Impact

If enacted, HB 1079 will impact Arkansas Code Title 23, specifically by adding a subchapter that outlines the requirements for health benefit plans regarding coverage for genetic testing and cancer imaging. It will assure that individuals with personal or family histories of cancer will have access to this critical testing and imaging, significantly impacting the preventive healthcare landscape in Arkansas. The legislation is positioned to enhance early detection and management strategies for individuals at higher risk of cancer, potentially leading to better health outcomes.

Summary

House Bill 1079 is a proposed legislation aimed at mandating coverage for genetic testing for inherited gene mutations and evidence-based cancer imaging for certain individuals. By establishing specific criteria under which these medical services must be covered by health benefit plans, the bill seeks to improve access to essential health services for individuals at risk of hereditary cancers. The bill defines genetic testing, emphasizing the requirement for clinical utility and support by established medical guidelines, thereby ensuring that the testing is not only relevant but also beneficial to patient treatment and outcomes.

Contention

One of the notable points of contention surrounding HB 1079 revolves around the implications for insurance providers and the costs associated with mandated coverage. Proponents argue that the benefits of early detection will justify the costs, potentially decreasing long-term healthcare expenses related to untreated cancers. However, some critics may express concern over the financial burden on insurance companies and the feasibility of implementing such mandates, especially in a state where healthcare costs are a significant concern. This discourse highlights the broader national conversation about healthcare access and insurance coverage for specialized medical services.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.